Clinical applicability of renin-angiotensin system inhibitors in cancer treatment.
Hui‐Rong Jiang, Zongguang Tai, Zhongjian Chen, Quangang Zhu, Leilei Bao
Abstract
, an essential component of RAS, on tumors, and we discuss the underlying biological mechanism of RASi. Furthermore, we outline the research progress and potential use of RASi in tumor treatment. Overall, RASi may be a promising adjunct in cancer therapy.
Topics & Concepts
MetastasisCancer researchAngiogenesisRenin–angiotensin systemCancerIn vivoBioinformaticsMedicineBiologyInternal medicineGeneticsBlood pressureFerroptosis and cancer prognosisRenin-Angiotensin System StudiesComputational Drug Discovery Methods